Dr. Jesper Andersen

Biography

The Andersen group utilizes genome-wide approaches to model disease causality and stratifies patients to advance diagnostic and prognostic biomarkers and novel therapeutic options. Research is focused on three main project themes: Immunogenomics, metabolism, and epigenomic remodeling. The outcome research significantly guides novel treatment modalities and impacts the clinic to improve patients’ outcomes. Prof. Jesper B. Andersen received his PhD in 2006 from the Department of Molecular and Structural Biology at Aarhus University, Denmark, after completing a joint research fellowship from 2003 to 2007 at the University of Maryland, Department of Medicine. In 2007, Prof. Andersen joined the National Cancer Institute as a postdoctoral fellow. In 2014, he moved to the Biotech Research Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, where he started his own group focusing on biomedical translational research in primary liver and bile duct cancers. He was tenured in 2019 and appointed full Professor of Translational Hepatology in 2023. Prof. Andersen has authored or co-authored more than 150 seminal papers and book chapters and has been awarded multiple prestigious awards and fellowships for his contributions to cancer research.

Research Interests

Experience

Awards